Global Therapeutic Nuclear Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
LPI (LP Information)' newest research report, the “Therapeutic Nuclear Drug Industry Forecast” looks at past sales and reviews total world Therapeutic Nuclear Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Nuclear Drug sales for 2023 through 2029. With Therapeutic Nuclear Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Nuclear Drug industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Nuclear Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Nuclear Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Nuclear Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Nuclear Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Nuclear Drug.
The global Therapeutic Nuclear Drug market size is projected to grow from US$ 1634.7 million in 2022 to US$ 2085 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 47%, followed by Europe and Asia-Pac?
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
LPI (LP Information)' newest research report, the “Therapeutic Nuclear Drug Industry Forecast” looks at past sales and reviews total world Therapeutic Nuclear Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Therapeutic Nuclear Drug sales for 2023 through 2029. With Therapeutic Nuclear Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Nuclear Drug industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Nuclear Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Nuclear Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Nuclear Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Nuclear Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Nuclear Drug.
The global Therapeutic Nuclear Drug market size is projected to grow from US$ 1634.7 million in 2022 to US$ 2085 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 47%, followed by Europe and Asia-Pac?
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant DraxImage
- Lantheus
- Spectrum Pharmaceuticals
- Progenics Pharmaceuticals
- International Isotopes
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Nuclear Drug Market Size 2018-2029
2.1.2 Therapeutic Nuclear Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Therapeutic Nuclear Drug Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Nuclear Drug Market Size by Type
2.3.1 Therapeutic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
2.4 Therapeutic Nuclear Drug Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Nuclear Drug Market Size by Application
2.5.1 Therapeutic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
3 THERAPEUTIC NUCLEAR DRUG MARKET SIZE BY PLAYER
3.1 Therapeutic Nuclear Drug Market Size Market Share by Players
3.1.1 Global Therapeutic Nuclear Drug Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Nuclear Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 THERAPEUTIC NUCLEAR DRUG BY REGIONS
4.1 Therapeutic Nuclear Drug Market Size by Regions (2018-2023)
4.2 Americas Therapeutic Nuclear Drug Market Size Growth (2018-2023)
4.3 APAC Therapeutic Nuclear Drug Market Size Growth (2018-2023)
4.4 Europe Therapeutic Nuclear Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Therapeutic Nuclear Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Therapeutic Nuclear Drug Market Size by Country (2018-2023)
5.2 Americas Therapeutic Nuclear Drug Market Size by Type (2018-2023)
5.3 Americas Therapeutic Nuclear Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Nuclear Drug Market Size by Region (2018-2023)
6.2 APAC Therapeutic Nuclear Drug Market Size by Type (2018-2023)
6.3 APAC Therapeutic Nuclear Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Therapeutic Nuclear Drug by Country (2018-2023)
7.2 Europe Therapeutic Nuclear Drug Market Size by Type (2018-2023)
7.3 Europe Therapeutic Nuclear Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Nuclear Drug by Region (2018-2023)
8.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL THERAPEUTIC NUCLEAR DRUG MARKET FORECAST
10.1 Global Therapeutic Nuclear Drug Forecast by Regions (2024-2029)
10.1.1 Global Therapeutic Nuclear Drug Forecast by Regions (2024-2029)
10.1.2 Americas Therapeutic Nuclear Drug Forecast
10.1.3 APAC Therapeutic Nuclear Drug Forecast
10.1.4 Europe Therapeutic Nuclear Drug Forecast
10.1.5 Middle East & Africa Therapeutic Nuclear Drug Forecast
10.2 Americas Therapeutic Nuclear Drug Forecast by Country (2024-2029)
10.2.1 United States Therapeutic Nuclear Drug Market Forecast
10.2.2 Canada Therapeutic Nuclear Drug Market Forecast
10.2.3 Mexico Therapeutic Nuclear Drug Market Forecast
10.2.4 Brazil Therapeutic Nuclear Drug Market Forecast
10.3 APAC Therapeutic Nuclear Drug Forecast by Region (2024-2029)
10.3.1 China Therapeutic Nuclear Drug Market Forecast
10.3.2 Japan Therapeutic Nuclear Drug Market Forecast
10.3.3 Korea Therapeutic Nuclear Drug Market Forecast
10.3.4 Southeast Asia Therapeutic Nuclear Drug Market Forecast
10.3.5 India Therapeutic Nuclear Drug Market Forecast
10.3.6 Australia Therapeutic Nuclear Drug Market Forecast
10.4 Europe Therapeutic Nuclear Drug Forecast by Country (2024-2029)
10.4.1 Germany Therapeutic Nuclear Drug Market Forecast
10.4.2 France Therapeutic Nuclear Drug Market Forecast
10.4.3 UK Therapeutic Nuclear Drug Market Forecast
10.4.4 Italy Therapeutic Nuclear Drug Market Forecast
10.4.5 Russia Therapeutic Nuclear Drug Market Forecast
10.5 Middle East & Africa Therapeutic Nuclear Drug Forecast by Region (2024-2029)
10.5.1 Egypt Therapeutic Nuclear Drug Market Forecast
10.5.2 South Africa Therapeutic Nuclear Drug Market Forecast
10.5.3 Israel Therapeutic Nuclear Drug Market Forecast
10.5.4 Turkey Therapeutic Nuclear Drug Market Forecast
10.5.5 GCC Countries Therapeutic Nuclear Drug Market Forecast
10.6 Global Therapeutic Nuclear Drug Forecast by Type (2024-2029)
10.7 Global Therapeutic Nuclear Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Therapeutic Nuclear Drug Product Offered
11.1.3 Bayer Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Therapeutic Nuclear Drug Product Offered
11.2.3 Novartis Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Information
11.3.2 China Isotope & Radiation Therapeutic Nuclear Drug Product Offered
11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 China Isotope & Radiation Main Business Overview
11.3.5 China Isotope & Radiation Latest Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Information
11.4.2 Dongcheng Therapeutic Nuclear Drug Product Offered
11.4.3 Dongcheng Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dongcheng Main Business Overview
11.4.5 Dongcheng Latest Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Information
11.5.2 Q BioMed Therapeutic Nuclear Drug Product Offered
11.5.3 Q BioMed Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Q BioMed Main Business Overview
11.5.5 Q BioMed Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Therapeutic Nuclear Drug Product Offered
11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Company Information
11.7.2 Jubilant DraxImage Therapeutic Nuclear Drug Product Offered
11.7.3 Jubilant DraxImage Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Jubilant DraxImage Main Business Overview
11.7.5 Jubilant DraxImage Latest Developments
11.8 Lantheus
11.8.1 Lantheus Company Information
11.8.2 Lantheus Therapeutic Nuclear Drug Product Offered
11.8.3 Lantheus Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lantheus Main Business Overview
11.8.5 Lantheus Latest Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Company Information
11.9.2 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product Offered
11.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Spectrum Pharmaceuticals Main Business Overview
11.9.5 Spectrum Pharmaceuticals Latest Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Company Information
11.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Drug Product Offered
11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Progenics Pharmaceuticals Main Business Overview
11.10.5 Progenics Pharmaceuticals Latest Developments
11.11 International Isotopes
11.11.1 International Isotopes Company Information
11.11.2 International Isotopes Therapeutic Nuclear Drug Product Offered
11.11.3 International Isotopes Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 International Isotopes Main Business Overview
11.11.5 International Isotopes Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Nuclear Drug Market Size 2018-2029
2.1.2 Therapeutic Nuclear Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Therapeutic Nuclear Drug Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Nuclear Drug Market Size by Type
2.3.1 Therapeutic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
2.4 Therapeutic Nuclear Drug Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Nuclear Drug Market Size by Application
2.5.1 Therapeutic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
3 THERAPEUTIC NUCLEAR DRUG MARKET SIZE BY PLAYER
3.1 Therapeutic Nuclear Drug Market Size Market Share by Players
3.1.1 Global Therapeutic Nuclear Drug Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Nuclear Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 THERAPEUTIC NUCLEAR DRUG BY REGIONS
4.1 Therapeutic Nuclear Drug Market Size by Regions (2018-2023)
4.2 Americas Therapeutic Nuclear Drug Market Size Growth (2018-2023)
4.3 APAC Therapeutic Nuclear Drug Market Size Growth (2018-2023)
4.4 Europe Therapeutic Nuclear Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Therapeutic Nuclear Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Therapeutic Nuclear Drug Market Size by Country (2018-2023)
5.2 Americas Therapeutic Nuclear Drug Market Size by Type (2018-2023)
5.3 Americas Therapeutic Nuclear Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Nuclear Drug Market Size by Region (2018-2023)
6.2 APAC Therapeutic Nuclear Drug Market Size by Type (2018-2023)
6.3 APAC Therapeutic Nuclear Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Therapeutic Nuclear Drug by Country (2018-2023)
7.2 Europe Therapeutic Nuclear Drug Market Size by Type (2018-2023)
7.3 Europe Therapeutic Nuclear Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Nuclear Drug by Region (2018-2023)
8.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL THERAPEUTIC NUCLEAR DRUG MARKET FORECAST
10.1 Global Therapeutic Nuclear Drug Forecast by Regions (2024-2029)
10.1.1 Global Therapeutic Nuclear Drug Forecast by Regions (2024-2029)
10.1.2 Americas Therapeutic Nuclear Drug Forecast
10.1.3 APAC Therapeutic Nuclear Drug Forecast
10.1.4 Europe Therapeutic Nuclear Drug Forecast
10.1.5 Middle East & Africa Therapeutic Nuclear Drug Forecast
10.2 Americas Therapeutic Nuclear Drug Forecast by Country (2024-2029)
10.2.1 United States Therapeutic Nuclear Drug Market Forecast
10.2.2 Canada Therapeutic Nuclear Drug Market Forecast
10.2.3 Mexico Therapeutic Nuclear Drug Market Forecast
10.2.4 Brazil Therapeutic Nuclear Drug Market Forecast
10.3 APAC Therapeutic Nuclear Drug Forecast by Region (2024-2029)
10.3.1 China Therapeutic Nuclear Drug Market Forecast
10.3.2 Japan Therapeutic Nuclear Drug Market Forecast
10.3.3 Korea Therapeutic Nuclear Drug Market Forecast
10.3.4 Southeast Asia Therapeutic Nuclear Drug Market Forecast
10.3.5 India Therapeutic Nuclear Drug Market Forecast
10.3.6 Australia Therapeutic Nuclear Drug Market Forecast
10.4 Europe Therapeutic Nuclear Drug Forecast by Country (2024-2029)
10.4.1 Germany Therapeutic Nuclear Drug Market Forecast
10.4.2 France Therapeutic Nuclear Drug Market Forecast
10.4.3 UK Therapeutic Nuclear Drug Market Forecast
10.4.4 Italy Therapeutic Nuclear Drug Market Forecast
10.4.5 Russia Therapeutic Nuclear Drug Market Forecast
10.5 Middle East & Africa Therapeutic Nuclear Drug Forecast by Region (2024-2029)
10.5.1 Egypt Therapeutic Nuclear Drug Market Forecast
10.5.2 South Africa Therapeutic Nuclear Drug Market Forecast
10.5.3 Israel Therapeutic Nuclear Drug Market Forecast
10.5.4 Turkey Therapeutic Nuclear Drug Market Forecast
10.5.5 GCC Countries Therapeutic Nuclear Drug Market Forecast
10.6 Global Therapeutic Nuclear Drug Forecast by Type (2024-2029)
10.7 Global Therapeutic Nuclear Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Therapeutic Nuclear Drug Product Offered
11.1.3 Bayer Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Therapeutic Nuclear Drug Product Offered
11.2.3 Novartis Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Information
11.3.2 China Isotope & Radiation Therapeutic Nuclear Drug Product Offered
11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 China Isotope & Radiation Main Business Overview
11.3.5 China Isotope & Radiation Latest Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Information
11.4.2 Dongcheng Therapeutic Nuclear Drug Product Offered
11.4.3 Dongcheng Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dongcheng Main Business Overview
11.4.5 Dongcheng Latest Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Information
11.5.2 Q BioMed Therapeutic Nuclear Drug Product Offered
11.5.3 Q BioMed Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Q BioMed Main Business Overview
11.5.5 Q BioMed Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Therapeutic Nuclear Drug Product Offered
11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Company Information
11.7.2 Jubilant DraxImage Therapeutic Nuclear Drug Product Offered
11.7.3 Jubilant DraxImage Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Jubilant DraxImage Main Business Overview
11.7.5 Jubilant DraxImage Latest Developments
11.8 Lantheus
11.8.1 Lantheus Company Information
11.8.2 Lantheus Therapeutic Nuclear Drug Product Offered
11.8.3 Lantheus Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lantheus Main Business Overview
11.8.5 Lantheus Latest Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Company Information
11.9.2 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product Offered
11.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Spectrum Pharmaceuticals Main Business Overview
11.9.5 Spectrum Pharmaceuticals Latest Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Company Information
11.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Drug Product Offered
11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Progenics Pharmaceuticals Main Business Overview
11.10.5 Progenics Pharmaceuticals Latest Developments
11.11 International Isotopes
11.11.1 International Isotopes Company Information
11.11.2 International Isotopes Therapeutic Nuclear Drug Product Offered
11.11.3 International Isotopes Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 International Isotopes Main Business Overview
11.11.5 International Isotopes Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Nuclear Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Radium-223
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Iodine-131
Table 5. Major Players of Other
Table 6. Therapeutic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 9. Therapeutic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Therapeutic Nuclear Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Therapeutic Nuclear Drug Revenue Market Share by Player (2018-2023)
Table 14. Therapeutic Nuclear Drug Key Players Head office and Products Offered
Table 15. Therapeutic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Therapeutic Nuclear Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Therapeutic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Therapeutic Nuclear Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Therapeutic Nuclear Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Therapeutic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Therapeutic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Therapeutic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Therapeutic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Therapeutic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Therapeutic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Therapeutic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Therapeutic Nuclear Drug
Table 47. Key Market Challenges & Risks of Therapeutic Nuclear Drug
Table 48. Key Industry Trends of Therapeutic Nuclear Drug
Table 49. Global Therapeutic Nuclear Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Therapeutic Nuclear Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Therapeutic Nuclear Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Bayer Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 54. Bayer Therapeutic Nuclear Drug Product Offered
Table 55. Bayer Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 59. Novartis Therapeutic Nuclear Drug Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. China Isotope & Radiation Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 64. China Isotope & Radiation Therapeutic Nuclear Drug Product Offered
Table 65. China Isotope & Radiation Main Business
Table 66. China Isotope & Radiation Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. China Isotope & Radiation Latest Developments
Table 68. Dongcheng Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 69. Dongcheng Therapeutic Nuclear Drug Product Offered
Table 70. Dongcheng Main Business
Table 71. Dongcheng Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Dongcheng Latest Developments
Table 73. Q BioMed Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 74. Q BioMed Therapeutic Nuclear Drug Product Offered
Table 75. Q BioMed Main Business
Table 76. Q BioMed Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Q BioMed Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Therapeutic Nuclear Drug Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Curium Pharmaceuticals Latest Developments
Table 83. Jubilant DraxImage Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 84. Jubilant DraxImage Therapeutic Nuclear Drug Product Offered
Table 85. Jubilant DraxImage Main Business
Table 86. Jubilant DraxImage Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Jubilant DraxImage Latest Developments
Table 88. Lantheus Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 89. Lantheus Therapeutic Nuclear Drug Product Offered
Table 90. Lantheus Main Business
Table 91. Lantheus Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Lantheus Latest Developments
Table 93. Spectrum Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 94. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product Offered
Table 95. Spectrum Pharmaceuticals Main Business
Table 96. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Spectrum Pharmaceuticals Latest Developments
Table 98. Progenics Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 99. Progenics Pharmaceuticals Therapeutic Nuclear Drug Product Offered
Table 100. Progenics Pharmaceuticals Main Business
Table 101. Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Progenics Pharmaceuticals Latest Developments
Table 103. International Isotopes Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 104. International Isotopes Therapeutic Nuclear Drug Product Offered
Table 105. International Isotopes Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. International Isotopes Main Business
Table 107. International Isotopes Latest Developments
Table 1. Therapeutic Nuclear Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Radium-223
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Iodine-131
Table 5. Major Players of Other
Table 6. Therapeutic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 9. Therapeutic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Therapeutic Nuclear Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Therapeutic Nuclear Drug Revenue Market Share by Player (2018-2023)
Table 14. Therapeutic Nuclear Drug Key Players Head office and Products Offered
Table 15. Therapeutic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Therapeutic Nuclear Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Therapeutic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Therapeutic Nuclear Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Therapeutic Nuclear Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Therapeutic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Therapeutic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Therapeutic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Therapeutic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Therapeutic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Therapeutic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Therapeutic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Therapeutic Nuclear Drug
Table 47. Key Market Challenges & Risks of Therapeutic Nuclear Drug
Table 48. Key Industry Trends of Therapeutic Nuclear Drug
Table 49. Global Therapeutic Nuclear Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Therapeutic Nuclear Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Therapeutic Nuclear Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Bayer Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 54. Bayer Therapeutic Nuclear Drug Product Offered
Table 55. Bayer Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 59. Novartis Therapeutic Nuclear Drug Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. China Isotope & Radiation Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 64. China Isotope & Radiation Therapeutic Nuclear Drug Product Offered
Table 65. China Isotope & Radiation Main Business
Table 66. China Isotope & Radiation Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. China Isotope & Radiation Latest Developments
Table 68. Dongcheng Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 69. Dongcheng Therapeutic Nuclear Drug Product Offered
Table 70. Dongcheng Main Business
Table 71. Dongcheng Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Dongcheng Latest Developments
Table 73. Q BioMed Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 74. Q BioMed Therapeutic Nuclear Drug Product Offered
Table 75. Q BioMed Main Business
Table 76. Q BioMed Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Q BioMed Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Therapeutic Nuclear Drug Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Curium Pharmaceuticals Latest Developments
Table 83. Jubilant DraxImage Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 84. Jubilant DraxImage Therapeutic Nuclear Drug Product Offered
Table 85. Jubilant DraxImage Main Business
Table 86. Jubilant DraxImage Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Jubilant DraxImage Latest Developments
Table 88. Lantheus Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 89. Lantheus Therapeutic Nuclear Drug Product Offered
Table 90. Lantheus Main Business
Table 91. Lantheus Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Lantheus Latest Developments
Table 93. Spectrum Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 94. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product Offered
Table 95. Spectrum Pharmaceuticals Main Business
Table 96. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Spectrum Pharmaceuticals Latest Developments
Table 98. Progenics Pharmaceuticals Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 99. Progenics Pharmaceuticals Therapeutic Nuclear Drug Product Offered
Table 100. Progenics Pharmaceuticals Main Business
Table 101. Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Progenics Pharmaceuticals Latest Developments
Table 103. International Isotopes Details, Company Type, Therapeutic Nuclear Drug Area Served and Its Competitors
Table 104. International Isotopes Therapeutic Nuclear Drug Product Offered
Table 105. International Isotopes Therapeutic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. International Isotopes Main Business
Table 107. International Isotopes Latest Developments
LIST OF FIGURES
Figure 1. Therapeutic Nuclear Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Therapeutic Nuclear Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Therapeutic Nuclear Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Therapeutic Nuclear Drug Sales Market Share by Country/Region (2022)
Figure 8. Therapeutic Nuclear Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Therapeutic Nuclear Drug Market Size Market Share by Type in 2022
Figure 10. Therapeutic Nuclear Drug in Thyroid
Figure 11. Global Therapeutic Nuclear Drug Market: Thyroid (2018-2023) & ($ Millions)
Figure 12. Therapeutic Nuclear Drug in Bone Metastasis
Figure 13. Global Therapeutic Nuclear Drug Market: Bone Metastasis (2018-2023) & ($ Millions)
Figure 14. Therapeutic Nuclear Drug in Lymphoma
Figure 15. Global Therapeutic Nuclear Drug Market: Lymphoma (2018-2023) & ($ Millions)
Figure 16. Therapeutic Nuclear Drug in Other
Figure 17. Global Therapeutic Nuclear Drug Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Therapeutic Nuclear Drug Market Size Market Share by Application in 2022
Figure 19. Global Therapeutic Nuclear Drug Revenue Market Share by Player in 2022
Figure 20. Global Therapeutic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Therapeutic Nuclear Drug Value Market Share by Country in 2022
Figure 26. United States Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Therapeutic Nuclear Drug Market Size Market Share by Region in 2022
Figure 31. APAC Therapeutic Nuclear Drug Market Size Market Share by Type in 2022
Figure 32. APAC Therapeutic Nuclear Drug Market Size Market Share by Application in 2022
Figure 33. China Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Therapeutic Nuclear Drug Market Size Market Share by Country in 2022
Figure 40. Europe Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Therapeutic Nuclear Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Therapeutic Nuclear Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Therapeutic Nuclear Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Therapeutic Nuclear Drug Sales Market Share by Country/Region (2022)
Figure 8. Therapeutic Nuclear Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Therapeutic Nuclear Drug Market Size Market Share by Type in 2022
Figure 10. Therapeutic Nuclear Drug in Thyroid
Figure 11. Global Therapeutic Nuclear Drug Market: Thyroid (2018-2023) & ($ Millions)
Figure 12. Therapeutic Nuclear Drug in Bone Metastasis
Figure 13. Global Therapeutic Nuclear Drug Market: Bone Metastasis (2018-2023) & ($ Millions)
Figure 14. Therapeutic Nuclear Drug in Lymphoma
Figure 15. Global Therapeutic Nuclear Drug Market: Lymphoma (2018-2023) & ($ Millions)
Figure 16. Therapeutic Nuclear Drug in Other
Figure 17. Global Therapeutic Nuclear Drug Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Therapeutic Nuclear Drug Market Size Market Share by Application in 2022
Figure 19. Global Therapeutic Nuclear Drug Revenue Market Share by Player in 2022
Figure 20. Global Therapeutic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Therapeutic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Therapeutic Nuclear Drug Value Market Share by Country in 2022
Figure 26. United States Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Therapeutic Nuclear Drug Market Size Market Share by Region in 2022
Figure 31. APAC Therapeutic Nuclear Drug Market Size Market Share by Type in 2022
Figure 32. APAC Therapeutic Nuclear Drug Market Size Market Share by Application in 2022
Figure 33. China Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Therapeutic Nuclear Drug Market Size Market Share by Country in 2022
Figure 40. Europe Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Therapeutic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Therapeutic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Therapeutic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Therapeutic Nuclear Drug Market Size Market Share Forecast by Application (2024-2029)
